Global Phakic Intraocular Lenses (IOL) Market Size study, By Product (Posterior Chamber Phakic IOL, Anterior Chamber Phakic IOL), By Indication (Myopia, Hyperopia, Astigmatism), By End User (Hospitals, Ophthalmology Clinics, Ambulatory Surgical Centers),

Global Phakic Intraocular Lenses (IOL) Market Size study, By Product (Posterior Chamber Phakic IOL, Anterior Chamber Phakic IOL), By Indication (Myopia, Hyperopia, Astigmatism), By End User (Hospitals, Ophthalmology Clinics, Ambulatory Surgical Centers), and Regional Forecasts 2022-2028

Global Phakic Intraocular Lenses (IOL) Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. The Phakic Intraocular Lenses (IOL) also known as phakic lenses, are lenses made of plastic or silicone that are implanted into the eye permanently to reduce a person's need for glasses and contact lenses. Phakic lenses are utilized to correct refractive errors, errors in the eye's focusing power. All phakic lenses approved by the FDA are for the correction of nearsightedness (myopia). The growing prevalence of myopia and increasing awareness towards Phakic Lens Implant Surgery as well as strategic initiatives from leading market players are factors that are accelerating the global market demand. For instance, according to International Myopia Institute estimates – as of 2021, around 30% of global population is myopic and this number is projected to grow to 50% by 2050. Further, there would be around 1 billion high myopes by 2050. Countries such as South Korea, Taiwan, Singapore, China and Japan have a prevalence of myopia of 80 to 90 %. Furthermore, leading market players are working towards strategic initiatives including product approvals and new product launches to capitalize the growing demand for Phakic Intraocular Lenses. For instance, in December 2019, Johnson & Johnson Vision*, received the Food and Drug Administration (FDA) approval for U.S. launch of its new product TECNIS Toric II 1-Piece Intraocular Lens (IOL). Moreover, in January 2021, Alcon unveiled its new AcrySof IQ Vivity IOL in the United States. This new intraocular lens is intended for patients undergoing cataract surgery. This new product is a first-of-its-kind, non-diffractive extended depth of focus IOL. Also, growing healthcare sector in emerging economies coupled with rising per capita healthcare spending are anticipated to act as a catalyzing factor for the market demand during the forecast period. However, a lack of reimbursements for implantation procedures and availability of alternative treatment option impedes the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Phakic Intraocular Lenses (IOL) Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the growing number of product clearance and presence of leading market players. Whereas, Asia Pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as the thriving growth of healthcare sector and increasing incidences of myopia in the region, would create lucrative growth prospects for the global Phakic Intraocular Lenses (IOL) Market across the Asia Pacific.

Major market players included in this report are:
Rayner Surgical Group Limited
Care Group
Ophtec BV/Abbott
Johnson & Johnson
Staar Surgical
USIOL Inc.
Omni Lens Pvt Ltd
Zeiss
Aurolab
HOYA Corporation

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Posterior Chamber Phakic IOL
Anterior Chamber Phakic IOL
By Indication:
Myopia
Hyperopia
Astigmatism
By End User:
Hospitals
Ophthalmology Clinics
Ambulatory Surgical Centers
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Phakic Intraocular Lenses (IOL) Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

Rayner Surgical Group Limited
Care Group
Ophtec BV/Abbott
Johnson & Johnson
Staar Surgical
USIOL Inc.
Omni Lens Pvt Ltd
Zeiss
Aurolab
HOYA Corporation

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.